Company Profile

Boron Biologicals Inc (AKA: BBI)
Profile last edited on: 6/4/08      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1986
First Award
1989
Latest Award
1999
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

620 Hutton Street Suite 104
Raleigh, NC 27606
   (919) 832-2044
   N/A
   N/A
Location: Single
Congr. District: 04
County: Wake

Public Profile

Boron Biologicals is focused on the design, synthesis and commercial use of boronated organic compounds.. BBI's patented boronated nucleosides offer strong promise in the emerging fields of antisense and gene therapy. Boron Neutron Capture Therapy is a promising approach for the treatment of primary brain cancer and melanoma, as well as anti-osteoporotic, anti-viral and anti-cancer compounds

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1999 1 NIH $100,000
Project Title: New B22h222 For Neutron Capture And Diagnostics
1995 1 NIH $100,000
Project Title: P-Carboranylalanine Analogs of BPA for NCT
1995 1 NIH $100,000
Project Title: Selective Silver Staining of DNA Probes
1994 1 NIH $79,380
Project Title: Boronated asparagine and glutamine analogs for BNCT
1994 2 NIH $545,256
Project Title: Nucleoside Phosphate Analogues with Boronated Phosphates

Key People / Management

  Bernard F Spielvogel -- President

  Anup Sood

Company News

There are no news available.